Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |